The crystal structure of a triterpene component of Wyethia mollis has been obtained and compared with the previously reported structure of the compound. The compound in the crystal structure, lanosta-8,24-dien-3-one, 16,23-epoxy-(16β, 23R), (1), is different from the previously reported compound, but has identical NMR and mass spectrometric data. The revised structure contains a tetrahydropyran E ring, a structural moiety rare in steroid triterpenes.
KanematsuA., NatoriS. (1972) Triterpenoids of Echinodontium tsugicola. Chemical & Pharmaceutical Bulletin.20, 1993–1999.
4.
(a) NianY., ZhangX-M, LiY., WangY-Y, ChenJ-C, LuL., ZhouL., QiuM-H. (2011) Cycloartane triterpenoids from the aerial parts of Cimicifuga foetida Linnaeus. Phytochemistry, 72, 1473–1481; (b) Nian Y, Chen J-C, Lu L, Zhang X-M, Zhou L, Qiu M-H. (2009) Four new 9,19-cyclolanostane derivatives from the rhizomes of Cimicifuga yunnanensis Hsiao. Helvetica Chimica Acta.92, 112-120; (c) Einbond LS, Ye W-C, He K, Wu H-a, Cruz E, Roller M, Kronenberg F. (2008) Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells. Phytomedicine, 15, 504-511; (d) Sakurai N, Kozuka M, Tokuda H, Nobukuni Y, Takayasu J, Nishino H, Kusano A, Kusano G, Nagai M, Sakurai Y, Lee K-H. (2003) Antitumor agents 220. Antitumor-promoting effects of cimigenol and related compounds on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Bioorganic and Medicinal Chemistry, 11, 1137-1140; (e) Shao Y, Harris A, Wang M, Zhang H, Cordell GA, Bowman M, Lemmo E. (2000) Triterpene glycosides from Cimicifuga racemosa. Journal of Natural Products, 63, 905-910; (f) Zhou L, Yang J, Zou J, Tu G. (2004) Three new cycloartane triterpene glycosides from Souliea vaginata. Chemical & Pharmaceutical Bulletin, 52, 622-624; (g) Zhou L, Yang J-S, Tu G-Z, Zou J-H. (2006) Cyclolanostane triterpene glycosides from Souliea vaginata. Chemical & Pharmaceutical Bulletin, 54, 823-826.
5.
FujitaM., NakaoY., MatsunagaS., SeikiM., ItohY., van SoestW.M., HeubesM., FaulknerD.J., FusetaniN. (2001) Isolation and structure elucidation of two phosphorylated sterol sulfates, MT1-MMP inhibitors from a marine sponge Cribrochalina sp.: revision of the structures of haplosamates A and B. Tetrahedron, 57, 3885–3890.
6.
ChianeseG., FattorussoE., Taglialatela-ScafatiO., BavestrelloG., CalcinaiB., DienH.A., LigrestiA., DiM.V. (2011) Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligand. Steroids, 76, 998–1002.
7.
KurodaM., MimakiY., SashidaY., HiranoT., OkaK., DobashiA., LiH-y, HaradaN. (1997) Novel cholestane glycosides from the bulbs of Ornithogalum saundersiae and their cytostatic activity on leukemia HL-60 and MOLT-4 cells. Tetrahedron, 53, 11549–11562.
8.
KurodaM., MimakiY., SashidaY., YamoriT., TsuruoT. (2000) Galtonioside A, a novel cytotoxic cholestane glycoside from Galtonia candicans.Tetrahedron Letters, 41, 251–255.
9.
KurodaM., MimakiY., SashidaY., YamoriT., TsuruoT. (1999) Cholestane glycosides from Galtonia candicans and their cytostatic activity on malignant tumor cells. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 41, 529–534.
10.
KurodaM., MimakiY., SashidaY., HiranoT., OkaK., DobashiA. (1995) A novel 16,23-epoxy-5β-cholestane glycoside with potent inhibitory activity on proliferation of human peripheral blood lymphocytes from Ornithogalum saundersiae bulbs. Chemical & Pharmaceutical Bulletin, 43, 1257–1259.
11.
KusanoG., TakahashiA., SugiyamaK., NozoeS. (1987) Antifungal properties of solanum alkaloids. Chemical & Pharmaceutical Bulletin, 35, 4862–4867.
12.
LiscovitchM., LavieY. (2001) Use of steroidal alkaloids to reverse multidrug resistance. WO2001049279A2.
13.
ZengL., PenX., ZhangR.Y. (1995) Alizexol A, a novel protostane type of triterpene from Alisma orientalis (SAM) Juzep. Chinese Chemical Letters, 6, 675–678.
14.
BronkB.S., AustinW.F., CreaserS.P., FindeisM.A., FullerN.O., HubbsJ.L., IvesJ.L., ShenR. (2011) Preparation of cholestane derivatives useful for treating neurodegenerative disorders. WO2011109657A1.
15.
FindeisM.A. (2007) Compounds useful for treating neurodegenerative disorders. US20070149491A1.
16.
SheldrickG.M. (2008) A short history of SHELX. Acta Crystallographica A, 64, 112–122.
